Fact CheckerSign in

NCT07561801Completed

Pentoxifylline for Prevention of Contrast Induced Nephropathy in Chronic Kidney Diseased Patients in Intensive Care Unit

The Role of Pentoxifylline for Prevention of Contrast Induced Nephropathy in Chronic Kidney Diseased Patients in Intensive Care Unit

Source: ClinicalTrials.gov · Last updated 1 May 2026

Brief summary (registry, in English)

The aim of this study is to evaluate the effect of pentoxifylline for control of contrast induced nephropathy in chronic kidney diseased patients in intensive care unit.

Status (registry)
Completed
Study type
Interventional
Enrollment
70 (actual)
First submitted
25 Apr 2026
Start date
1 Jul 2024
Primary completion date
1 Jun 2025
Lead sponsor
Tanta University
NCT number
NCT07561801

What you commit to

  • Study type: Interventional
  • Participants enrolled: 70
  • From 1 Jul 2024 to the primary completion date, 1 Jun 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with CKD on renal replacement therapy.

Other illness

  • Respiratory failure.
  • Cardiac failure.
  • Liver failure.
  • Methylxanthines hypersensitivity.

Who the study is looking for

  • Age from 18 to 65 years.
  • Both sexes.
  • The presence of chronic kidney disease (CKD) is defined according to the National Kidney Foundation-kidney disease Outcomes Quality Initiative guidelines with second or third stage.
  • Urgent patients expected taking dye in stable cases of cardiac catheterization or pulmonary embolism with Geneva score (4-11).

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tanta university
Coordinator of this site? Confirm its status
TantaEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.